MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'approved'. Sat, 03 Sep 2011 01:59:46 +0100 http://www.medworm.com/index.php?rid=5028517&cid=t_101855_111_f&fid=39123&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fnursingcomments%2Ftdtc%2F%7E3%2FTIy93UnlV6M%2F I was doing some research on clinical trials and it is much more complex than I dreamed!  First of all, any new treatment must go through numerous stages of testing before its benefits and risks can completely be known.  New treatments are discovered in the laboratory and it can take many years of research before they are given to patients.  Why?  Because it is essential to identify that the new treatment is actually better than what is already available.  These research studies are also called clinical trials.  If a treatment has definite potential in the final stages of development, then research is carried out in patients with the particular type of illness that the treatment aims to help.  Furthermore, I always believed that clinical trials were only regarding drugs, and that is... Nursing Comments blogs http://www.medworm.com/rss/comments.php?id=5028517 Thu, 14 Jul 2011 15:37:10 +0100 5028517 http://www.medworm.com/index.php?rid=4968489&cid=t_101855_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Ffda-approved-drugs-are-not-always-effective-the-benefits-of-alternative-medicine%2F2011.06.25 On Saturday, while thousands of Boston Bruins fans gathered at Government Center to celebrate the team’s recent Stanley Cup victory, a hundred or so true die-hards met a few blocks away at a Massachusetts General Hospital conference to talk about complementary and alternative medicine for psychiatric disorders. While I hated to miss the Bruins parade, I’m glad I attended the MGH conference. I’ve always been a bit of a skeptic about so-called natural therapies for one simple reason: they don’t have to go through the same rigorous testing in clinical trials that medications do. At the same time, I realize that FDA-approved drugs don’t work for everyone. One in three adults with major depression, for example, can’t completely improve their mood and other symptoms even after trying... Better Health blogs http://www.medworm.com/rss/comments.php?id=4968489 Sat, 25 Jun 2011 21:00:31 +0100 4968489 http://www.medworm.com/index.php?rid=4077389&cid=t_101855_117_f&fid=38158&url=http%3A%2F%2Fwww.twitter.com%2Famacupuncturehttp%3A%2F%2Famericanacupuncture.blogspot.com%2F2010%2F10%2Fbotox-approved-for-chronic-migraines.html BOTOX APPROVED FOR CHRONIC MIGRAINES  Many doctors have been using Botox for unapproved uses as headache and pain. Now  the FDA has approved the drug to treat chronic migraines.The current pain medications for chronic migraines are rarely effective and do not prevent future migraines. Over 12% of Americans suffer from throbbing pulsating pain of migraines.The Botox drug company, Allergan,  paid $600 million to settle criminal and civil allegations last month.   Botox is a pure live form of the toxin of botulinum,, and is a nerve poison produced by the bacteria that causes botulism. Injections paralyze nerves signals the certain muscles and glands.  A typical migraine Botox treatment involves 31 interjections and seven areas including the forehead, temples, bac... Dr. Needles Medical Blogs blogs http://www.medworm.com/rss/comments.php?id=4077389 Mon, 18 Oct 2010 02:09:00 +0100 4077389 http://www.medworm.com/index.php?rid=3721971&cid=t_101855_151_f&fid=36896&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FSuboxoneTalkZone%2F%7E3%2Fxc27AjUeZU8%2F Over a year ago I wrote about the transdermal formulation of buprenorphine available in Europe called ‘Butrans.’  One problem with the treatment of opioid dependence using buprenorphine has been the limited dose options available;  while 2 and 8 mg sublingual tablets are fine for maintenance, they are wholly inadequate when it comes to tapering off buprenorphine.  The ‘wall’ of withdrawal symptoms that people discover as they taper past 2 mg is a product of the ceiling effect of buprenorphine– so useful on the way up, but so challenging on the way down!  At 2 mg, the level part of the dose/response curve ends, and each decrease in dose causes a drop in opiate effect and a drop in tolerance… and so an increase in (albeit temporary) misery.  Smaller d... Suboxone Talk Zone blogs http://www.medworm.com/rss/comments.php?id=3721971 Sat, 03 Jul 2010 01:03:03 +0100 3721971 http://www.medworm.com/index.php?rid=3665971&cid=t_101855_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fflibanserin-another-pre-fda-approval-drug-hype%2F2010.06.15 This week the FDA will vote on flibanserin, the much-talked-about drug for women with the condition called hypoactive sexual desire disorder or — because everything in sexual health needs an acronym like ED or PE — HSDD. On the eve of the FDA vote, CBS last week ran still another story about flibanserin. This drug has received so much news coverage, you’d think it cures cancer. And CBS did little more than promote the hype even more, saying FDA approval “could translate into a $2 billion market in this country alone” and then failing to challenge the disease-mongering estimate of “10 percent to 30 percent of women” with this condition. It all just goes along with the drug company’s efforts to build a demand before the drug is even approved. (... Better Health blogs http://www.medworm.com/rss/comments.php?id=3665971 Wed, 16 Jun 2010 02:00:41 +0100 3665971 http://www.medworm.com/index.php?rid=3216730&cid=t_101855_129_f&fid=36038&url=http%3A%2F%2Fwww.everydayhealth.com%2Fblog%2Ftrevis-life-with-multiple-sclerosis-ms%2Ffda-approves-the-walking-pill-for-multiple-sclerosis%2F As of Friday afternoon, a long awaited addition to our arsenal of MS symptomatic drugs has been approved. We had a conversation about Ampyra which is a timed-release version of the drug 4-Aminopyridine (and formerly known as Fampridine SR), last May.  At that time the drug was being resubmitted to the FDA for approval (rejected, originally, due to “formatting issues” during the application process). This drug is thought to increase signal conduction by blocking tiny pore-like potassium channels on nerves of the central nervous system (CNS). The time-released part of the drug is what is new, for those of you who have been getting 4-Aminopyridine from compound pharmacies. Phase III clinical trials suggest that some 34-43 percent of people taking Ampyra had positive results in the areas ... Life with MS blogs http://www.medworm.com/rss/comments.php?id=3216730 Wed, 27 Jan 2010 23:01:39 +0100 3216730 http://www.medworm.com/index.php?rid=3176015&cid=t_101855_122_f&fid=35055&url=http%3A%2F%2Fsarasotaneurology.com%2F2010%2F01%2F15%2Fjama-reports-prp-not-effective-a-poorly-designed-study%2F In conclusion, PRP is a highly effective medical treatment for ligament, tendon, muscle and other knee/shoulder injuries as well as lower back pain. Even patients with post-operative knee pain or shoulder pain can benefit from PRP therapy.  Outcomes are entirely dependent on the preparation and handling of the blood, equipment used and experience as well as skill of the treating physician. Additional information on PRP can be found at PRP Stops Pain. Excellent clinical study references can be found by clicking here. (Source: Sarasota Neurology) Sarasota Neurology blogs http://www.medworm.com/rss/comments.php?id=3176015 Fri, 15 Jan 2010 14:20:35 +0100 3176015 http://www.medworm.com/index.php?rid=3079384&cid=t_101855_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2009%2F12%2F11%2Ffda-wants-your-comments-on-ect%2F The good folks over at the Committee for Truth in Psychiatry (a national organization for people who’ve had electroconvulsive therapy - ECT) wanted me to remind you that the U.S. Food and Drug Administration (FDA) is seeking comments on the safety and efficacy of electroconvulsive devices. You may not be aware, but these devices — which deliver electrical impulses to your brain! — have never been tested by the FDA for either safety of efficacy. Let me repeat that – the FDA has never approved ECT devices for safety or efficacy. Doctors today can apply electrical impulses to your brain without having any government agency approve such treatment, despite the fact that ECT in most people results in sometimes-significant memory loss. We wrote about FDA’s desire to... World of Psychology blogs http://www.medworm.com/rss/comments.php?id=3079384 Fri, 11 Dec 2009 10:35:05 +0100 3079384 http://www.medworm.com/index.php?rid=2927454&cid=t_101855_122_f&fid=35055&url=http%3A%2F%2Fsarasotaneurology.com%2F2009%2F10%2F25%2Fregenerative-medicine-platelet-rich-plasma-provides-joint-pain-relief%2F As a neurologist who sees many patients with neck, back and various joint pains, I practice an area of medicine known as neuro-orthopedics. As such, I treat patients for their pain without surgical intervention. Many patients with neck, back and joint pain (knee pain, shoulder pain, elbow pain, etc.) can be successfully treated without invasive surgery and the many risk that go along with this. With surgery there is also a prolonged recovery time and need for extensive rehabilitation. The area of medicine that applies to successfully treating patients without surgery or use of narcotic medications is known as regenerative medicine. In this field, platelet rich plasma is injected into the affected joint, tendon, ligament or soft tissue area that has pain and is failing to heal completely. T... Sarasota Neurology blogs http://www.medworm.com/rss/comments.php?id=2927454 Sun, 25 Oct 2009 21:00:24 +0100 2927454 http://www.medworm.com/index.php?rid=2902859&cid=t_101855_117_f&fid=38158&url=http%3A%2F%2Fwww.drneedles.comhttp%3A%2F%2Famericanacupuncture.blogspot.com%2F2009%2F10%2Fgardisil-vaccinations-for-boys-approved.html As a medical physician for over 51 years, I strive to give you the best medical information on controversial medical subjects, and help your read betwwen the lines. You must come to your own conclusions. I have no ties to any organization, pharmaceutical, or lobby group. As an practicing medical acupuncturist since 1982, I find western medicine and medical acupuncture are very complimentary. This results in astounding healing in pain management, addictions to cigarettes and food, and a host of other maladies. Visit drneedles is blogging" at the end of each blog for a complete alphabetical list of all my blogs Visit http://www.americanacupuncture.com/ for more detailed information on mind, body, and spirit healing.GARDISIL VACCINATIONS FOR BOYS APPROVED Are you willing to have your son vacc... Dr. Needles Medical Blogs blogs http://www.medworm.com/rss/comments.php?id=2902859 Sat, 17 Oct 2009 22:13:00 +0100 2902859 http://www.medworm.com/index.php?rid=2453174&cid=t_101855_149_f&fid=35786&url=http%3A%2F%2Fkinasepro.wordpress.com%2F2009%2F06%2F03%2Ftoceranib%2F aka Palladia, PHA-291639, & SU11654 got its FDA Approval today! Well… In dogs at least:.  It’s for canine mast cell tumors. yeh, its the pyrrolidine version of Sutent & its the phosphate salt Posted in Approved, Pfizer (Source: KinasePro) KinasePro blogs http://www.medworm.com/rss/comments.php?id=2453174 Thu, 04 Jun 2009 02:33:34 +0100 2453174 http://www.medworm.com/index.php?rid=2167479&cid=t_101855_87_f&fid=34825&url=http%3A%2F%2Fwww.wesleyjsmith.com%2Fblog%2F2009%2F02%2Ffirst-pharming-drug-approved.html Dolly the sheep was cloned because the administrator Ian Wilmut, and the team that did the deed, hoped to create a herd of genetically altered sheep through cloning and inserting human genes that would result in the sheep producing milk containing properties that could be extracted and turned into medicine--a process dubbed "pharming." That enterprise failed financially and Wilmut went onto human cloning research before quitting that--good for him--to pursue induced pluripotent stem cell (IPSC) investigations.Where Wilmut and team failed, a different group succeeded. The first medicine derived through pharming has received FDA approval. From the story:U.S. health officials on Friday approved the first drug made using genetically engineered animals despite lingering concerns over health and... Secondhand Smoke blogs http://www.medworm.com/rss/comments.php?id=2167479 Fri, 06 Feb 2009 22:47:00 +0100 2167479 http://www.medworm.com/index.php?rid=1895043&cid=t_101855_131_f&fid=34989&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FGeneticsHealth%2F%7E3%2Fq27N3Quhfbc%2F Medications that have been slowing the mental decline in Alzheimer’s patients are showing promise as drugs that can boost the mental skills of children with Down Syndrome. Two of those promising drugs are Aricept and Exelon, which were found to increase skill levels of Down syndrome children in small clinical trials. Aricept and Exelon are FDA-approved drugs for treating Alzheimer’s. Doctors had observed that adults with Down Syndrome were developing Alzheimer’s disease at an earlier age than the general population. The drugs were given to children, in appropriate doses, to test if they could delay the development of the illness. The results surprised the physicians. In a very short period of time, the children’s communication skills and understanding improved. Dr... Genetics and Health blogs http://www.medworm.com/rss/comments.php?id=1895043 Wed, 22 Oct 2008 08:24:32 +0100 1895043 http://www.medworm.com/index.php?rid=1870667&cid=t_101855_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2008%2F10%2F12%2Fseroquel-xr-gets-additional-approvals%2F Helping to extend Seroquel’s existing reach, AstraZeneca, its maker, has received U.S. Food and Drug Administration (FDA) approval to market it as an effective treatment not only for mania associated with bipolar disorder, but also now for depressive episodes in bipolar disorder too. According to the Reuters report on the news: The green light from the Food and Drug Administration makes Seroquel XR the first medication cleared in the United States for the once-daily acute treatment of both depressive and manic episodes associated with bipolar disorder. Seroquel was first approved for the treatment of schizophrenia in 1997 by the FDA, and for manic episodes of bipolar disorder in 2004. The government-funded CATIE trials demonstrated mixed efficacy for Seroquel. Such research has c... World of Psychology blogs http://www.medworm.com/rss/comments.php?id=1870667 Sun, 12 Oct 2008 19:51:50 +0100 1870667 http://www.medworm.com/index.php?rid=1866452&cid=t_101855_167_f&fid=37833&url=http%3A%2F%2Fnutrition.edublogs.org%2F2008%2F10%2F04%2Fwhat-cereals-can-i-feed-my-child-healthy-wic-approved-cereals%2F This week’s release of the report by Consumer Reports may have parents wondering what cereals they should be feeding their child/children.  One way is to see what cereals are recommended by the WIC program. WIC is a federally-funded health and nutrition program for women, infants, and children.  WIC helps families by providing checks for buying healthy supplemental foods from WIC-authorized vendors, nutrition education, and help finding healthcare and other community services. What makes a cereal a WIC Approved Cereal? WIC-approved cereals are ones that are low in sugar and have a lot of nutrients, vitamins and minerals in them. Two of the vitamins included in many of the cereals: Iron Folic Acid List of WIC Approved Cereals in California for Children All of these cereal are lo... Nutrition and Wellness Biology 50 blogs http://www.medworm.com/rss/comments.php?id=1866452 Thu, 09 Oct 2008 16:00:28 +0100 1866452 http://www.medworm.com/index.php?rid=1616025&cid=t_101855_109_f&fid=35044&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2Fadultaddstrengths%2FGVqP%2F%7E3%2F333468811%2F So now you know how the US Government feels about Adults with ADHD. 2nd class citizens? An after thought? We’ll eventually get around to you, but you’re not really that important. 8 Years. Count em. Almost a decade. It has been used off label for quite some time, but now it’s “officially approved” by the FDA as medication for adults with ADHD. Maybe it’s not just the FDA’s fault, maybe its the manufacturer’s Mcneil Pediatrics/ Janssen-Ortho. Maybe both. For the clinically inclined types, here’s the Medscape CME (free login required) on it. Here’s the detailed Concerta Prescribing Information PDF. If this Health Canada page is accurate, it looks like Concerta was approved for use in adults in Canada on April 15, 2008, nearly 3 mon... Adult ADD Strengths blogs http://www.medworm.com/rss/comments.php?id=1616025 Sat, 12 Jul 2008 11:34:04 +0100 1616025 http://www.medworm.com/index.php?rid=1603089&cid=t_101855_122_f&fid=35055&url=http%3A%2F%2Fsarasotaneurology.com%2F2008%2F07%2F10%2Fparkinson-disease-may-benefit-from-early-brain-stimulation%2F Recent studies have suggested that qualifying Parkinson patients benefit from earlier treatment with deep brain stimulation, as reported in Clinical Neurology News. The study indicates that younger Parkinson disease patients are more likely to benefit from early brain stimulator treatment. There is information that may suggest that this therapy may have a protective effect in delaying the progression of Parkinson’s disease. Deep brain stimulation (DBS) was FDA approved in 2002 for treatment of Parkinson’s disease. Symptoms that are best controlled include tremor and dyskinesias although brain stimulation can also help reduce freezing and off time. Younger Parkinson patients develop motor complications such as dyskinesias, off time and freezing much earlier than older patients w... Sarasota Neurology blogs http://www.medworm.com/rss/comments.php?id=1603089 Thu, 10 Jul 2008 10:00:33 +0100 1603089 http://www.medworm.com/index.php?rid=1531886&cid=t_101855_117_f&fid=36026&url=http%3A%2F%2Fblog.healthtalk.com%2Fzimney%2Fcymbalta-approved-for-fibromyalgia%2F The anti-depressant Cymbalta (duloxetine), marketed by Lilly, has received FDA approval for the treatment of fibromyalgia. While certain anti-depressants are considered first-line therapy for fibromyalgia, most notably the tricyclic anti-depressants such as amitriptyline, none had been approved by the FDA for this use until now. Cymbalta belongs to a newer class of anti-depressants known collectively as serotonin and norepinephrine reuptake inhibitors (SNRIs), which are somewhat similar to the serotonin reuptake inhibitors (SSRIs), of which Prozac, also marketed by Lilly, is the most widely known. Cymbalta is already marketed for the treatment of depression, anxiety and for pain associated with diabetic peripheral neuropathy. It was first approved for U.S. marketing in 2004. Cymbalta is no... Dr. Z's Medical Report blogs http://www.medworm.com/rss/comments.php?id=1531886 Thu, 19 Jun 2008 19:43:51 +0100 1531886 http://www.medworm.com/index.php?rid=1500096&cid=t_101855_111_f&fid=36048&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2F306988044%2F Heart transplants save the lives of more than 2,100 Americans every year. But many more patients are still waiting for a new heart to become available, and hundreds will die without ever getting a second chance at life. With that being said researchers are asking the question, “will heart transplants become a thing of the past?” Will technology become the answer? Yes and perhaps were the answers! The HeartMate II is an example of this technology. It is the size of a D-cell battery, with a tube that pokes through the skin and connects to a battery pack. It aids in pumping blood through the body as patients hearts fail. The HeartMate device has since been approved for use by the Food and Drug Administration (FDA) in April of 2008. Would you prefer technology to a heart trans... A Hearty Life blogs http://www.medworm.com/rss/comments.php?id=1500096 Sat, 07 Jun 2008 21:33:05 +0100 1500096 http://www.medworm.com/index.php?rid=1238153&cid=t_101855_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2008%2F02%2F17%2Ffda-to-drug-companies-off-label-use-ok%2F Doctors have always been able to prescribe whatever drug they want, for whatever they want. However, drug companies have only been allowed to advertise and market drugs that have been FDA-approved for specific uses or disorders. That means that generally an antidepressant drug can only be marketed and advertised for depression. If a company wants to market and advertise its drug for other uses, it has to go back to the U.S. Food and Drug Administration (FDA) and file additional applications, with a wealth of supporting research to support those uses. Unless the research is strong and the market is potentially lucrative, many pharmaceutical companies choose to limit the amount of additional uses they seek FDA approval for. Any use of a drug that hasn’t gained FDA approval is conside... World of Psychology blogs http://www.medworm.com/rss/comments.php?id=1238153 Mon, 18 Feb 2008 01:36:13 +0100 1238153 http://www.medworm.com/index.php?rid=989947&cid=t_101855_149_f&fid=35786&url=http%3A%2F%2Fkinasepro.wordpress.com%2F2007%2F10%2F30%2Ftasigna-approved%2F aka nilotinib, AMN-107 is a Novartis’ follow-on to Gleevecnow approved for CML. wiki; clinic; WO/2002/022597 (Source: KinasePro) KinasePro blogs http://www.medworm.com/rss/comments.php?id=989947 Tue, 30 Oct 2007 12:52:27 +0100 989947 http://www.medworm.com/index.php?rid=922073&cid=t_101855_149_f&fid=35786&url=http%3A%2F%2Fkinasepro.wordpress.com%2F2007%2F10%2F02%2F437%2F So what are they worth?  TotallyMedicinal’s got the low-low. TY TM for data: mirrored here. (Source: KinasePro) KinasePro blogs http://www.medworm.com/rss/comments.php?id=922073 Tue, 02 Oct 2007 22:21:22 +0100 922073 http://www.medworm.com/index.php?rid=589133&cid=t_101855_87_f&fid=34865&url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F05%2F04%2Fbreast-cancer-drug-herceptin-approved-in-europe%2F Filed under: Breast Cancer, Drug, Clinical Trials, Research, Daily newsBreast cancer drug Herceptin has been approved in Europe for use with hormonal therapy for postmenopausal patients with HER2 and hormone receptor positive metastatic disease.Herceptin, made by Swiss drugmaker Roche Holding AG, is already approved in Europe for early and metastatic HER2-positive breast cancer. This new approval is based on data from an international late stage clinical trial showing the combination of Herceptin with hormonal therapy doubled the median progression-free survival time.Read | Permalink | Email this | Linking Blogs | Comments (Source: The Cancer Blog) The Cancer Blog blogs http://www.medworm.com/rss/comments.php?id=589133 Fri, 04 May 2007 04:00:00 +0100 589133 http://www.medworm.com/index.php?rid=478736&cid=t_101855_87_f&fid=34865&url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F03%2F13%2Fbreast-cancer-drug-tykerb-wins-fda-approval%2F Filed under: Breast Cancer, Drug, Daily newsTykerb has been approved by the FDA for use in conjunction with the chemotherapy drug Xeloda. Tykerb is a cancer medication that more precisely targets tumors without killing lots of healthy cells in the process. Herceptin and Tykerb target a protein called HER-2/neu but work in different ways. Herceptin targets the outside of the HER2 protein and Tykerb works from the inside of the cell. This difference can give advanced breast cancer patients another drug to switch to if Herceptin stops working for them. Glaxo said that Tykerb will be available in two weeks. The results of a study showed that Tykerb worked so well that the international study was stopped early and all the participants were offered the drug. The FDA said it was too early to know... The Cancer Blog blogs http://www.medworm.com/rss/comments.php?id=478736 Tue, 13 Mar 2007 04:00:00 +0100 478736